← Back to Clinical Trials
Recruiting NCT06729190

NCT06729190 Effect of Biofeedback and Functional Electrical Stimulation in Children

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06729190
Status Recruiting
Phase
Sponsor Cairo University
Condition Hemiplegia
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2024-12
Primary Completion 2025-03

Eligibility & Interventions

Sex All sexes
Min Age 5 Years
Max Age 10 Years
Study Type INTERVENTIONAL
Interventions
biofeedbackPhysical therapy program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 40 participants in total. It began in 2024-12 with a primary completion date of 2025-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

40 children with hemiplegia cerebral palsy from both sex will be recruited from outpatient clinic of abo resh hospital ,their age ranged from 5-10 years

Eligibility Criteria

Inclusion Criteria: * Their age will range from 5 to 10 years. * Spasticity grade range from 1+ to 2, according to Modified Ashworth Scale (MAS) (Bohannon and Smith, 2011). * Their UL ability function will be at level II according to Manual Ability Classification System (MACS) (Penta et al., 2001). * They will be able to follow instructions. Exclusion Criteria: * Loss of sensation * The presence of visual or auditory impairments. * Musculoskeletal problems or fixed deformities in the upper extremities. * Seizures. * Surgical interference in upper limbs. * Botulinum toxin injections in the last 6 months.

Contact & Investigator

Central Contact

Alaa T Ramadan, M.SC

✉ dr.alaataha@yahoo.com

📞 01019320008

Principal Investigator

Khaled A Mamdouh, PHD

STUDY DIRECTOR

professor of physical therapy

Frequently Asked Questions

Who can join the NCT06729190 clinical trial?

This trial is open to participants of all sexes, aged 5 Years or older, up to 10 Years, studying Hemiplegia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06729190 currently recruiting?

Yes, NCT06729190 is actively recruiting participants. Contact the research team at dr.alaataha@yahoo.com for enrollment information.

Where is the NCT06729190 trial being conducted?

This trial is being conducted at Giza, Egypt.

Who is sponsoring the NCT06729190 clinical trial?

NCT06729190 is sponsored by Cairo University. The principal investigator is Khaled A Mamdouh, PHD at professor of physical therapy. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology